Immunovo
's-hertogenbosch, Noord-Brabant, The Netherlands
About Immunovo
Immunovo BV is a Dutch private biotechnology company, based in ‘s-Hertogenbosch, engaged in the discovery and clinical development of immunotherapeutics in the field of oncology. The key priority for Immunovo is on its proprietary Immune Activation System (IAS) based on combining synthetic peptide antigens with a novel immune stimulant (adjuvant).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Apr 2010)
- Website: immunovo.com
- Phone: +31 (0) 73 – 627 4520
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/immunovo-2548837 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.